.jpg?format=webp&width=780)
The study aimed to determine the occurrence of remission and one-year relapse from remission in patients with type 2 diabetes, as well as identify associated factors. The research included 48,320 Japanese patients with type 2 diabetes and followed them from 1989 until September 2022. Remission was defined as maintaining HbA1c levels below 48 mmol/mol after stopping glucose-lowering medication for at least three months. Relapse was defined as the inability to sustain remission for one year. Factors such as duration of diabetes, baseline HbA1c levels, body mass index (BMI), and BMI reduction were analyzed. The results indicated differences in remission rates and predictors of relapse, particularly BMI, between East Asian and Western populations. The findings suggested that East Asian populations may have stronger associations between BMI reduction and remission/relapse, suggesting ethnic disparities in transitioning from hyperglycemia to normal glucose levels.
Like
Save
Share